We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Method Suggested for Diagnosis of DVT

By LabMedica International staff writers
Posted on 03 Sep 2018
Print article
Image: An illustration depicting a deep vein thrombosis (Photo courtesy of Wikimedia Commons).
Image: An illustration depicting a deep vein thrombosis (Photo courtesy of Wikimedia Commons).
A simple blood test has been proposed as an alternative to the fairly costly and time intensive ultrasound procedure for diagnosis of deep vein thrombosis (DVT).

Investigators at the University of West Virginia (Morgantown, USA) have suggested that measuring the level of D-dimer protein in a patient’s blood may accurately predict whether a time-intensive ultrasound is warranted.

D-dimer (DD) protein is a fibrin degradation product fragment present in the blood after a blood clot is degraded by fibrinolysis. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link. D-dimer concentration may be determined by a blood test to help diagnose thrombosis. Since its introduction in the 1990s, it has become an important test performed in patients with suspected thrombotic disorders. While a negative result practically rules out thrombosis, a positive result can indicate thrombosis but does not rule out other potential causes. Its main use, therefore, is to exclude thromboembolic disease where the probability is low.

The DD level combined with the pretest Wells criteria probability (WCP) score can safely exclude DVT. The objective of the current study was to examine the correlation between DD results alongside WCP score with findings on venous duplex ultrasound (VDU).

To this end, the investigators initially reviewed the medical records of 360 patients who, over the course of one month, visited an emergency room with complaints of leg swelling and pain. In a follow-up study, they evaluated the results for 1,670 such patients.

Results revealed that all of the patients with elevated DD levels were eventually diagnosed with DVT, but that none of patients with normal levels were. In contrast, only 14% of patients who underwent ultrasound imaging tested positive for DVT.

“It is a very simple sample of blood, which is sent to the lab. And usually in 15 or 20 minutes, you have significant information that can help you take good care of the patients,” said senior author Dr. Albeir Mousa, professor of vascular surgery at West Virginia University. “And you can send patients home quicker, with less demand on the hospital staff and the institution, yet increase patient satisfaction. Usually waiting for a venous ultrasound would be a matter of three, four, five hours. With the D-dimer test, it is a few minutes and you are done.”

The D-dimer study was published in the July 18, 2018, issue of the Annals of Vascular Surgery.

Related Links:
University of West Virginia

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more